Forecasting Quarterly Sales Figures, page-58

Illuccix (TLX591-CDx) global distribution agreements

Telix has continued to build out its global distribution network for TLX591-CDx in preparation for regulatory decision notification and commercial launch in countries beyond Australia and the United States. During the quarter, Telix entered into the following agreements:

• Canada: Isologic Innovative Pharmaceuticals (Isologic) and Telix signed a licence and distribution agreement, appointing Isologic as the commercial distributor for Illuccix in Canada, once approved.
• Saudi Arabia: Abdulla Fouad for Medical Supplies and Services Company (AFMS) and Telix signed a licence and distribution agreement, appointing AFMS as the commercial distributor for Illuccix in the Kingdom of Saudi Arabia, once approved.

Telix now has commercial distribution agreements in place in all major European Union markets and the United Kingdom. In the APAC region, Telix has distribution agreements in place for Australia, New Zealand, Greater China (including Hong Kong, Taiwan, Macau) and South Korea. In the
Americas region (ex-U.S.) Telix has agreements in place for Canada and Brazil.